ProMIS Neurosciences Inc (PMN) insider trading

Every open-market stock purchase and sale by ProMIS Neurosciences Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Johanne Kaplan (C-suite exec) bought $30.3K in the last 90 days, growing their stake 58%.

Last 12 months: insiders bought $10.3M (6 buys) and sold $0 (0 sales). Last close $9.13 on Oct 21, 2026.

Recent PMN insider trades

DateInsiderTradeValue
Oct 5, 2026Ivana Rubino (C-suite exec)Bought (not open market)—
Aug 5, 2026Johanne Kaplan (C-suite exec)Bought$30.3K
May 20, 2026Slanix Paul Alex (Director)Bought (not open market)—
May 20, 2026Slanix Paul Alex (Director)Bought (not open market)—
May 20, 2026Neil Cashman (C-suite exec)Bought (not open market)—
May 20, 2026Johanne Kaplan (C-suite exec)Bought (not open market)—
May 20, 2026Josh Mandel-Brehm (Director)Bought (not open market)—
May 20, 2026Josh Mandel-Brehm (Director)Bought (not open market)—
May 20, 2026Max A. Milbury (Officer)Bought (not open market)—
May 20, 2026Madge K. Shafmaster (Director)Bought (not open market)—
May 20, 2026Neil K Warma (CEO)Bought (not open market)—
May 20, 2026Eugene Williams (Director)Bought (not open market)—
May 20, 2026Eugene Williams (Director)Bought (not open market)—
May 20, 2026William W Wyman (Director)Bought (not open market)—
May 20, 2026William W Wyman (Director)Bought (not open market)—
May 20, 2026Madge K. Shafmaster (Director)Bought (not open market)—
Apr 22, 2026Patrick D. Kirwin (Director)Bought$45.3K
Mar 5, 2026Eugene Williams (Director)Bought$48.8K
Mar 4, 2026Eugene Williams (Director)Bought$48K
Mar 3, 2026Eugene Williams (Director)Bought$21.9K
Mar 2, 2026Eugene Williams (Director)Bought$22.5K
Feb 19, 2026Johanne Kaplan (C-suite exec)Bought$25K
Feb 3, 2026ABG Management Ltd. (10% owner)Bought$10.1M
Feb 3, 2026Max A. Milbury (Insider)Bought (not open market)$95K
Feb 3, 2026Neil K Warma (CEO)Bought (not open market)$89K

Who's trading PMN

Get free alerts when an insider at ProMIS Neurosciences Inc files a new trade →